首页 > 最新文献

Journal of the Korean Surgical Society最新文献

英文 中文
Acute gastric volvulus treated with laparoscopic reduction and percutaneous endoscopic gastrostomy. 经皮内镜下胃造口术治疗急性胃扭转。
Pub Date : 2013-07-01 Epub Date: 2013-06-26 DOI: 10.4174/jkss.2013.85.1.47
Sang-Ho Jeong, Chang-Youn Ha, Young-Joon Lee, Sang-Kyung Choi, Soon-Chan Hong, Eun-Jung Jung, Young-Tae Ju, Chi-Young Jeong, Woo-Song Ha

Acute gastric volvulus requires emergency surgery, and a laparoscopic approach for both acute and chronic gastric volvulus was reported recently to give good results. The case of a 50-year-old patient with acute primary gastric volvulus who was treated by laparoscopic reduction and percutaneous endoscopic gastrostomy is described here. This approach seems to be feasible and safe for not only chronic gastric volvulus, but also acute gastric volvulus.

急性胃扭转需要紧急手术,最近有报道称腹腔镜治疗急性和慢性胃扭转效果良好。病例50岁的病人急性原发性胃扭转谁是腹腔镜复位和经皮内镜胃造口术治疗在这里被描述。这种方法不仅对慢性胃扭转可行,对急性胃扭转也是安全的。
{"title":"Acute gastric volvulus treated with laparoscopic reduction and percutaneous endoscopic gastrostomy.","authors":"Sang-Ho Jeong,&nbsp;Chang-Youn Ha,&nbsp;Young-Joon Lee,&nbsp;Sang-Kyung Choi,&nbsp;Soon-Chan Hong,&nbsp;Eun-Jung Jung,&nbsp;Young-Tae Ju,&nbsp;Chi-Young Jeong,&nbsp;Woo-Song Ha","doi":"10.4174/jkss.2013.85.1.47","DOIUrl":"https://doi.org/10.4174/jkss.2013.85.1.47","url":null,"abstract":"<p><p>Acute gastric volvulus requires emergency surgery, and a laparoscopic approach for both acute and chronic gastric volvulus was reported recently to give good results. The case of a 50-year-old patient with acute primary gastric volvulus who was treated by laparoscopic reduction and percutaneous endoscopic gastrostomy is described here. This approach seems to be feasible and safe for not only chronic gastric volvulus, but also acute gastric volvulus. </p>","PeriodicalId":49991,"journal":{"name":"Journal of the Korean Surgical Society","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2013-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.4174/jkss.2013.85.1.47","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"31563107","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 24
Comparison of neoadjuvant adriamycin and docetaxel versus adriamycin, cyclophosphamide followed by paclitaxel in patients with operable breast cancer. 可手术乳腺癌患者新辅助阿霉素和多西他赛与阿霉素、环磷酰胺和紫杉醇的比较。
Pub Date : 2013-07-01 Epub Date: 2013-06-26 DOI: 10.4174/jkss.2013.85.1.7
Woo Sung Hong, Ja Young Jeon, Seok Yun Kang, Yong Sik Jung, Ji Young Kim, Mi Sun Ahn, Doo Kyoung Kang, Tae Hee Kim, Hyun Ee Yim, Young-Sil An, Rae Woong Park, Ku Sang Kim

Purpose: Neoadjuvant chemotherapy is the standard treatment for patients with locally advanced breast cancer and is increasingly considered for patients with operable disease. Recently, as many clinical trials have demonstrated favorable outcomes of anthracycline-taxane based regimen, this approach has been widely used in the neoadjuvant setting.

Methods: We compared women who received adriamycine and docetaxel (AD) with adriamycin, cyclophosphamide followed by paclitaxel (AC-T) as neoadjuvant chemotherapy. The AD group was scheduled for six cycles of AD (50 mg/m(2) and 75 mg/m(2), respectively) at a 3-week interval. The AC-T group was scheduled for four cycles of adriamycin and cyclophosphamide (50 mg/m(2) and 500 mg/m(2), respectively) followed by four cycles of paclitaxel (175 mg/m(2)) at a 3-week interval.

Results: The responses of chemotherapy were equivalent (overall response rate [AD, 75.7% vs. AC-T, 80.9%; P = 0.566], pathologic complete response [pCR] rate [breast and axilla: AD, 10.8% vs. AC-T, 12.8%; P = 1.000; breast only: AD, 18.9% vs. AC-T, 14.9%, P = 0.623], breast conserving surgery rate [P = 0.487], and breast conserving surgery conversion rate [P = 0.562]). The pCR rate in the breast was higher in the human epidermal growth factor receptor 2 (HER2) positive cases (HER2 positive 33.3% vs. negative 10%, P = 0.002). Although nonhematologic toxicities were comparable, hematologic toxicities were more severe in the AD group. Most women in the AD group suffered from grade 3/4 neutropenia (P < 0.001) and neutropenic fever (P < 0.001).

Conclusion: Tumor responses were not different in various variables between the two groups. However, AC-T was a more tolerable regimen than AD in patients with breast cancer receiving neoadjuvant chemotherapy.

目的:新辅助化疗是局部晚期乳腺癌患者的标准治疗方法,并越来越多地被考虑用于可手术患者。最近,由于许多临床试验已经证明了蒽环类-紫杉烷为主的方案的良好效果,该方法已被广泛应用于新辅助治疗。方法:我们比较阿霉素加多西他赛(AD)与阿霉素加环磷酰胺加紫杉醇(AC-T)作为新辅助化疗的女性。AD组以3周为间隔进行6个AD周期(分别为50 mg/m(2)和75 mg/m(2))。AC-T组安排阿霉素和环磷酰胺(分别为50 mg/m(2)和500 mg/m(2)) 4个周期,然后紫杉醇(175 mg/m(2)) 4个周期,间隔3周。结果:化疗反应相当(总缓解率[AD, 75.7% vs. AC-T, 80.9%;P = 0.566],病理完全缓解率[乳腺和腋窝:AD, 10.8% vs. AC-T, 12.8%;P = 1.000;乳房:AD, 18.9% vs. AC-T, 14.9%, P = 0.623],保乳手术率[P = 0.487],保乳手术转换率[P = 0.562])。人表皮生长因子受体2 (HER2)阳性乳腺组织的pCR率较高(HER2阳性33.3% vs.阴性10%,P = 0.002)。虽然非血液学毒性比较,但AD组的血液学毒性更严重。AD组大多数女性出现3/4级中性粒细胞减少(P < 0.001)和中性粒细胞减少热(P < 0.001)。结论:两组肿瘤疗效在各指标上无明显差异。然而,在接受新辅助化疗的乳腺癌患者中,AC-T方案比AD方案更耐受。
{"title":"Comparison of neoadjuvant adriamycin and docetaxel versus adriamycin, cyclophosphamide followed by paclitaxel in patients with operable breast cancer.","authors":"Woo Sung Hong,&nbsp;Ja Young Jeon,&nbsp;Seok Yun Kang,&nbsp;Yong Sik Jung,&nbsp;Ji Young Kim,&nbsp;Mi Sun Ahn,&nbsp;Doo Kyoung Kang,&nbsp;Tae Hee Kim,&nbsp;Hyun Ee Yim,&nbsp;Young-Sil An,&nbsp;Rae Woong Park,&nbsp;Ku Sang Kim","doi":"10.4174/jkss.2013.85.1.7","DOIUrl":"https://doi.org/10.4174/jkss.2013.85.1.7","url":null,"abstract":"<p><strong>Purpose: </strong>Neoadjuvant chemotherapy is the standard treatment for patients with locally advanced breast cancer and is increasingly considered for patients with operable disease. Recently, as many clinical trials have demonstrated favorable outcomes of anthracycline-taxane based regimen, this approach has been widely used in the neoadjuvant setting.</p><p><strong>Methods: </strong>We compared women who received adriamycine and docetaxel (AD) with adriamycin, cyclophosphamide followed by paclitaxel (AC-T) as neoadjuvant chemotherapy. The AD group was scheduled for six cycles of AD (50 mg/m(2) and 75 mg/m(2), respectively) at a 3-week interval. The AC-T group was scheduled for four cycles of adriamycin and cyclophosphamide (50 mg/m(2) and 500 mg/m(2), respectively) followed by four cycles of paclitaxel (175 mg/m(2)) at a 3-week interval.</p><p><strong>Results: </strong>The responses of chemotherapy were equivalent (overall response rate [AD, 75.7% vs. AC-T, 80.9%; P = 0.566], pathologic complete response [pCR] rate [breast and axilla: AD, 10.8% vs. AC-T, 12.8%; P = 1.000; breast only: AD, 18.9% vs. AC-T, 14.9%, P = 0.623], breast conserving surgery rate [P = 0.487], and breast conserving surgery conversion rate [P = 0.562]). The pCR rate in the breast was higher in the human epidermal growth factor receptor 2 (HER2) positive cases (HER2 positive 33.3% vs. negative 10%, P = 0.002). Although nonhematologic toxicities were comparable, hematologic toxicities were more severe in the AD group. Most women in the AD group suffered from grade 3/4 neutropenia (P < 0.001) and neutropenic fever (P < 0.001).</p><p><strong>Conclusion: </strong>Tumor responses were not different in various variables between the two groups. However, AC-T was a more tolerable regimen than AD in patients with breast cancer receiving neoadjuvant chemotherapy.</p>","PeriodicalId":49991,"journal":{"name":"Journal of the Korean Surgical Society","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2013-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.4174/jkss.2013.85.1.7","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"31563100","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 6
Primary leiomyosarcoma of the thyroid. 原发性甲状腺平滑肌肉瘤。
Pub Date : 2013-07-01 Epub Date: 2013-06-26 DOI: 10.4174/jkss.2013.85.1.43
Bahadır Ege, Sezai Leventoğlu

A 56-year-old male with primary leiomyosarcoma of the thyroid is presented. The paucity of diagnostic maneuvers, including tumor markers, fine needle aspiration, and frozen section biopsy, are stressed, in addition to the fulminate course of the disease.

我们报告一位56岁男性原发性甲状腺平滑肌肉瘤。除了疾病的恶性病程外,还强调缺乏诊断手段,包括肿瘤标志物、细针穿刺和冷冻切片活检。
{"title":"Primary leiomyosarcoma of the thyroid.","authors":"Bahadır Ege,&nbsp;Sezai Leventoğlu","doi":"10.4174/jkss.2013.85.1.43","DOIUrl":"https://doi.org/10.4174/jkss.2013.85.1.43","url":null,"abstract":"<p><p>A 56-year-old male with primary leiomyosarcoma of the thyroid is presented. The paucity of diagnostic maneuvers, including tumor markers, fine needle aspiration, and frozen section biopsy, are stressed, in addition to the fulminate course of the disease. </p>","PeriodicalId":49991,"journal":{"name":"Journal of the Korean Surgical Society","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2013-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.4174/jkss.2013.85.1.43","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"31563106","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 12
Clinical impact of fat clearing technique in nodal staging of rectal cancer after preoperative chemoradiotherapy. 脂肪清除技术对直肠癌术前放化疗后淋巴结分期的临床影响。
Pub Date : 2013-07-01 Epub Date: 2013-06-26 DOI: 10.4174/jkss.2013.85.1.30
Im-Kyung Kim, Beom Jin Lim, Jeonghyun Kang, Seong-Ah Kim, Dongwon Kang, Seung-Kook Sohn, Kang Young Lee

Purpose: This study was designed to evaluate the efficacy of a fat clearing technique for accurate nodal staging of rectal cancer patients after preoperative chemoradiotherapy (CRT).

Methods: A total of 19 patients with rectal cancer within 10 cm from anal verge were divided into two groups: non-CRT group (n = 10) and CRT group (n = 9). For pathologic assessment, lymph node (LN) harvest was performed using conventional manual dissection followed by a fat clearing technique.

Results: A median of 3.0 additional LNs in non-CRT group and 3.8 LNs in CRT group were identified by the fat clearing technique. When subanalysis was performed in patients with fewer than 12 retrieved LNs, a median of 4.0 extra LNs in non-CRT group and 3.5 extra LNs in CRT group were identified after the fat clearing technique. None of additionally identified nodes were metastatic. In both groups, the median size of retrieved LNs following the fat clearing technique was smaller than that obtained by manual dissection (2.0 mm vs. 3.0 mm, P < 0.001).

Conclusion: The fat clearing technique allowed detection of additional LNs that were missed by the manual method, but these detected LNs were not proven to be metastatic.

目的:本研究旨在评估脂肪清除技术对直肠癌患者术前放化疗(CRT)后淋巴结准确分期的疗效。方法:将19例距肛缘10 cm以内的直肠癌患者分为非CRT组(n = 10)和CRT组(n = 9),采用常规手工清扫加清脂技术采集淋巴结进行病理评估。结果:非CRT组和CRT组的脂肪清除技术中位数分别增加了3.0和3.8个LNs。当对少于12个回收LNs的患者进行亚分析时,在脂肪清除技术后,非CRT组的中位额外LNs为4.0,CRT组的中位额外LNs为3.5。另外发现的淋巴结均未转移。在两组中,脂肪清除技术后获得的中位ln尺寸均小于手工剥离获得的中位ln (2.0 mm vs. 3.0 mm, P < 0.001)。结论:脂肪清除技术可以检测到手工方法遗漏的其他LNs,但这些检测到的LNs未被证明是转移性的。
{"title":"Clinical impact of fat clearing technique in nodal staging of rectal cancer after preoperative chemoradiotherapy.","authors":"Im-Kyung Kim,&nbsp;Beom Jin Lim,&nbsp;Jeonghyun Kang,&nbsp;Seong-Ah Kim,&nbsp;Dongwon Kang,&nbsp;Seung-Kook Sohn,&nbsp;Kang Young Lee","doi":"10.4174/jkss.2013.85.1.30","DOIUrl":"https://doi.org/10.4174/jkss.2013.85.1.30","url":null,"abstract":"<p><strong>Purpose: </strong>This study was designed to evaluate the efficacy of a fat clearing technique for accurate nodal staging of rectal cancer patients after preoperative chemoradiotherapy (CRT).</p><p><strong>Methods: </strong>A total of 19 patients with rectal cancer within 10 cm from anal verge were divided into two groups: non-CRT group (n = 10) and CRT group (n = 9). For pathologic assessment, lymph node (LN) harvest was performed using conventional manual dissection followed by a fat clearing technique.</p><p><strong>Results: </strong>A median of 3.0 additional LNs in non-CRT group and 3.8 LNs in CRT group were identified by the fat clearing technique. When subanalysis was performed in patients with fewer than 12 retrieved LNs, a median of 4.0 extra LNs in non-CRT group and 3.5 extra LNs in CRT group were identified after the fat clearing technique. None of additionally identified nodes were metastatic. In both groups, the median size of retrieved LNs following the fat clearing technique was smaller than that obtained by manual dissection (2.0 mm vs. 3.0 mm, P < 0.001).</p><p><strong>Conclusion: </strong>The fat clearing technique allowed detection of additional LNs that were missed by the manual method, but these detected LNs were not proven to be metastatic.</p>","PeriodicalId":49991,"journal":{"name":"Journal of the Korean Surgical Society","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2013-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.4174/jkss.2013.85.1.30","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"31563104","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
Preoperative constipation is associated with poor prognosis of rectal cancer: a prospective cohort study. 术前便秘与直肠癌预后不良相关:一项前瞻性队列研究
Pub Date : 2013-07-01 Epub Date: 2013-06-26 DOI: 10.4174/jkss.2013.85.1.35
Gil-Yong Lee, Sung-Min Lee, Je-Ho Jang, Heung-Kwon Oh, Duck-Woo Kim, Soyeon Ahn, Sung-Bum Kang

Purpose: It is unknown whether patients with advanced rectal cancer develop severe constipation. Therefore, the objective of this study was to assess whether constipation severity is associated with pathologic progression of rectal cancer.

Methods: We analyzed 472 patients with rectal cancer who underwent elective surgical resection between January 2005 and December 2010. Constipation severity was prospectively evaluated in 407 patients (86.2%) using the Cleveland Clinic Constipation Score System. Linear regression analysis was performed to identify clinicopathologic variables associated with constipation. Kaplan-Meier analysis and Cox proportional hazard models were used to evaluate the prognostic value of constipation severity on disease-free and overall survival.

Results: Multivariable analysis showed that sex (regression coefficient [B] = 1.55; 95% confidence interval [CI], 0.79 to 2.60; P < 0.001), body mass index (B = -0.95; 95% CI, -1.83 to -0.64; P = 0.036), tumor size (B = 1.04; 95% CI, 0.20 to 1.88; P = 0.016), T stage (B = 0.75; 95% CI, 0.23 to 1.27; P = 0.005), and distant metastasis (B = 1.16; 95% CI, 0.03 to 2.30; P = 0.045) were associated with constipation severity. Severe constipation (score ≥ 8) was independently associated with 3-year disease-free survival (vs. scores of 0-3; hazard ratio [HR], 2.39; 95% CI, 1.15 to 4.98; P = 0.020) and 5-year overall survival (HR, 2.30; 95% CI, 1.23 to 4.30; P = 0.009) in multivariable analysis.

Conclusion: Our results suggest that preoperative constipation severity is associated with advanced pathologic stage and poor oncologic outcomes in patients with rectal cancer.

目的:尚不清楚晚期直肠癌患者是否会出现严重的便秘。因此,本研究的目的是评估便秘严重程度是否与直肠癌的病理进展有关。方法:我们分析了2005年1月至2010年12月期间接受择期手术切除的472例直肠癌患者。使用克利夫兰诊所便秘评分系统对407例患者(86.2%)的便秘严重程度进行前瞻性评估。进行线性回归分析以确定与便秘相关的临床病理变量。采用Kaplan-Meier分析和Cox比例风险模型评价便秘严重程度对无病生存期和总生存期的预后价值。结果:多变量分析显示,性别(回归系数[B] = 1.55;95%置信区间[CI], 0.79 ~ 2.60;P < 0.001),体重指数(B = -0.95;95% CI, -1.83 ~ -0.64;P = 0.036)、肿瘤大小(B = 1.04;95% CI, 0.20 ~ 1.88;P = 0.016), T期(B = 0.75;95% CI, 0.23 ~ 1.27;P = 0.005),远处转移(B = 1.16;95% CI, 0.03 ~ 2.30;P = 0.045)与便秘严重程度相关。严重便秘(评分≥8)与3年无病生存独立相关(评分0-3;风险比[HR], 2.39;95% CI, 1.15 ~ 4.98;P = 0.020)和5年总生存率(HR, 2.30;95% CI, 1.23 ~ 4.30;P = 0.009)。结论:我们的研究结果表明,术前便秘严重程度与直肠癌患者的晚期病理分期和不良肿瘤预后相关。
{"title":"Preoperative constipation is associated with poor prognosis of rectal cancer: a prospective cohort study.","authors":"Gil-Yong Lee,&nbsp;Sung-Min Lee,&nbsp;Je-Ho Jang,&nbsp;Heung-Kwon Oh,&nbsp;Duck-Woo Kim,&nbsp;Soyeon Ahn,&nbsp;Sung-Bum Kang","doi":"10.4174/jkss.2013.85.1.35","DOIUrl":"https://doi.org/10.4174/jkss.2013.85.1.35","url":null,"abstract":"<p><strong>Purpose: </strong>It is unknown whether patients with advanced rectal cancer develop severe constipation. Therefore, the objective of this study was to assess whether constipation severity is associated with pathologic progression of rectal cancer.</p><p><strong>Methods: </strong>We analyzed 472 patients with rectal cancer who underwent elective surgical resection between January 2005 and December 2010. Constipation severity was prospectively evaluated in 407 patients (86.2%) using the Cleveland Clinic Constipation Score System. Linear regression analysis was performed to identify clinicopathologic variables associated with constipation. Kaplan-Meier analysis and Cox proportional hazard models were used to evaluate the prognostic value of constipation severity on disease-free and overall survival.</p><p><strong>Results: </strong>Multivariable analysis showed that sex (regression coefficient [B] = 1.55; 95% confidence interval [CI], 0.79 to 2.60; P < 0.001), body mass index (B = -0.95; 95% CI, -1.83 to -0.64; P = 0.036), tumor size (B = 1.04; 95% CI, 0.20 to 1.88; P = 0.016), T stage (B = 0.75; 95% CI, 0.23 to 1.27; P = 0.005), and distant metastasis (B = 1.16; 95% CI, 0.03 to 2.30; P = 0.045) were associated with constipation severity. Severe constipation (score ≥ 8) was independently associated with 3-year disease-free survival (vs. scores of 0-3; hazard ratio [HR], 2.39; 95% CI, 1.15 to 4.98; P = 0.020) and 5-year overall survival (HR, 2.30; 95% CI, 1.23 to 4.30; P = 0.009) in multivariable analysis.</p><p><strong>Conclusion: </strong>Our results suggest that preoperative constipation severity is associated with advanced pathologic stage and poor oncologic outcomes in patients with rectal cancer.</p>","PeriodicalId":49991,"journal":{"name":"Journal of the Korean Surgical Society","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2013-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.4174/jkss.2013.85.1.35","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"31563105","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Clinical implications of preoperative thyrotropin serum concentrations in patients who underwent thyroidectomy for nonfunctioning nodule(s). 无功能结节行甲状腺切除术患者术前血清促甲状腺素浓度的临床意义。
Pub Date : 2013-07-01 Epub Date: 2013-06-26 DOI: 10.4174/jkss.2013.85.1.15
Dongju Kim, Jin-Woo Park

Purpose: Thyroid stimulating hormone (TSH) measurement is the most sensitive screening test for thyroid dysfunction. TSH is a well-known thyroid growth factor but its pathogenic role in thyroid oncogenesis remains to be clarified. The purpose of the present study was to evaluate the relationship between clinicopathologic characteristics of nonfunctioning thyroid nodules and preoperative TSH serum concentrations.

Methods: Serum TSH concentrations can be affected by many factors. After exclusion of these confounding factors, a total of 126 patients who underwent thyroidectomy from Januray 2009 to December 2010 were included in this study. Average age was 45.4 ± 10.6 years and male:female ratio was 1:2.9. There were 11 patients with benign nodules, 34 patients with papillary thyroid microcarcinoma (PTMC) of less than 5 mm in maximal diameter, 66 patients with PTMCs of more than 5 mm but not more than 10 mm in maximal diameter, and 15 patients with papillary thyroid carcinoma (PTC) of more than 10 mm in maximal diameter.

Results: TNM stages of PTCs correlated with higher preoperative TSH serum concentrations. There were trends of higher preoperative TSH serum concentrations in patients who had extrathyroidal extension (P = 0.059) and advanced N stages (P = 0.120) but did not reach statistical significance. Patients' age, sex, and tumor volume did not seem to affect preoperative TSH serum concentrations significantly.

Conclusion: In patients who have PTCs without clinical, immunological, or ultrasonographic evidence of thyroiditis, higher preoperative TSH serum concentrations within the normal range might suggest advanced TNM stages.

目的:促甲状腺激素(TSH)测定是甲状腺功能障碍最敏感的筛查方法。TSH是一种众所周知的甲状腺生长因子,但其在甲状腺肿瘤发生中的致病作用尚不清楚。本研究的目的是评估无功能甲状腺结节的临床病理特征与术前血清TSH浓度之间的关系。方法:血清TSH浓度受多种因素影响。排除这些混杂因素后,2009年1月至2010年12月接受甲状腺切除术的患者共126例纳入本研究。平均年龄45.4±10.6岁,男女比例为1:9 .9。良性结节11例,最大直径小于5mm的甲状腺乳头状小癌34例,最大直径大于5mm但不大于10mm的甲状腺乳头状小癌66例,最大直径大于10mm的甲状腺乳头状小癌15例。结果:ptc的TNM分期与术前血清TSH浓度升高相关。甲状腺外展及N期晚期患者术前TSH浓度有升高趋势(P = 0.059),但差异无统计学意义(P = 0.120)。患者的年龄、性别和肿瘤体积似乎对术前TSH血清浓度没有显著影响。结论:在没有甲状腺炎临床、免疫学或超声证据的ptc患者中,术前正常范围内较高的TSH血清浓度可能提示TNM晚期。
{"title":"Clinical implications of preoperative thyrotropin serum concentrations in patients who underwent thyroidectomy for nonfunctioning nodule(s).","authors":"Dongju Kim,&nbsp;Jin-Woo Park","doi":"10.4174/jkss.2013.85.1.15","DOIUrl":"https://doi.org/10.4174/jkss.2013.85.1.15","url":null,"abstract":"<p><strong>Purpose: </strong>Thyroid stimulating hormone (TSH) measurement is the most sensitive screening test for thyroid dysfunction. TSH is a well-known thyroid growth factor but its pathogenic role in thyroid oncogenesis remains to be clarified. The purpose of the present study was to evaluate the relationship between clinicopathologic characteristics of nonfunctioning thyroid nodules and preoperative TSH serum concentrations.</p><p><strong>Methods: </strong>Serum TSH concentrations can be affected by many factors. After exclusion of these confounding factors, a total of 126 patients who underwent thyroidectomy from Januray 2009 to December 2010 were included in this study. Average age was 45.4 ± 10.6 years and male:female ratio was 1:2.9. There were 11 patients with benign nodules, 34 patients with papillary thyroid microcarcinoma (PTMC) of less than 5 mm in maximal diameter, 66 patients with PTMCs of more than 5 mm but not more than 10 mm in maximal diameter, and 15 patients with papillary thyroid carcinoma (PTC) of more than 10 mm in maximal diameter.</p><p><strong>Results: </strong>TNM stages of PTCs correlated with higher preoperative TSH serum concentrations. There were trends of higher preoperative TSH serum concentrations in patients who had extrathyroidal extension (P = 0.059) and advanced N stages (P = 0.120) but did not reach statistical significance. Patients' age, sex, and tumor volume did not seem to affect preoperative TSH serum concentrations significantly.</p><p><strong>Conclusion: </strong>In patients who have PTCs without clinical, immunological, or ultrasonographic evidence of thyroiditis, higher preoperative TSH serum concentrations within the normal range might suggest advanced TNM stages.</p>","PeriodicalId":49991,"journal":{"name":"Journal of the Korean Surgical Society","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2013-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.4174/jkss.2013.85.1.15","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"31563101","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 11
Achievement of the National Kidney Foundation Kidney Disease Outcomes Quality Initiative: recommended serum calcium, phosphate and parathyroid hormone values with parathyroidectomy in patients with secondary hyperparathyroidism. 国家肾脏基金会肾病结局质量倡议的实现:继发性甲状旁腺功能亢进患者行甲状旁腺切除术时推荐的血清钙、磷酸盐和甲状旁腺激素值。
Pub Date : 2013-07-01 Epub Date: 2013-06-26 DOI: 10.4174/jkss.2013.85.1.25
Woo Young Kim, Jae Bok Lee, Hoon Yub Kim, Sang Uk Woo, Gil Soo Son, Jeoung Won Bae

Purpose: The National Kidney Foundation Kidney Disease Outcomes Quality Initiative (NKF-K/DOQI) 2003 has established guidelines for the treatment of secondary hyperparathyroidism (SHPT) in patients with chronic kidney disease - minerals and bone disorder (CKD-MBD). This study evaluated parathyroidectomy in SHPT patients for the achievement of the NKF-K/DOQI-recommended values of serum calcium, phosphate, and parathyroid hormone (PTH).

Methods: Between January 2005 and December 2010, parathyroidectomy was performed as recommended by the NKF-K/DOQI guidelines in 81 patients with SHPT and CKD-MBD. Serum PTH, calcium, and phosphate levels were measured prior to and 6, 12, 36, and 60 months after parathyroidectomy.

Results: Calcium, phosphate, and PTH levels dropped shortly after parathyroidectomy; however, a slight increase showed in the long term. Calcium levels increased for up to 60 months. Phosphate and PTH levels increased for up to 36 months but tended to decrease slightly at 60 months. The mean values were within the target ranges, except for PTH at 36 months. The target parameters of serum phosphate (42.9-61.1% of patients) and serum calcium (a peak of 61.1% of patients at 36 months, but only 28.6% at 60 months) were achieved the most. Less than 34% of patients achieved the recommended range for PTH.

Conclusion: Parathyroidectomy was not an optimal procedure for achieving all the biochemical parameters recommended by the NKF-K/DOQI. Although it was helpful in attaining the recommended values for serum calcium and phosphate in SHPT patients resistant to medical therapy, the PTH levels did not fall within the recommended range.

目的:2003年国家肾脏基金会肾脏疾病结局质量倡议(NKF-K/DOQI)建立了慢性肾脏疾病-矿物质和骨骼疾病(CKD-MBD)患者继发性甲状旁腺功能亢进(SHPT)的治疗指南。本研究评估了SHPT患者行甲状旁腺切除术后血清钙、磷酸盐和甲状旁腺激素(PTH)达到NKF-K/ doqi推荐值的效果。方法:2005年1月至2010年12月,按照NKF-K/DOQI指南的建议,对81例SHPT和CKD-MBD患者行甲状旁腺切除术。在甲状旁腺切除术前、6、12、36和60个月后测定血清PTH、钙和磷酸盐水平。结果:甲状旁腺切除术后不久,钙、磷酸盐和甲状旁腺激素水平下降;然而,从长期来看,略有增长。在长达60个月的时间里,钙水平一直在上升。磷酸盐和甲状旁腺激素水平在36个月时升高,但在60个月时略有下降。除36个月时PTH外,平均值均在目标范围内。血清磷酸盐(42.9-61.1%)和血清钙(36个月时达到61.1%的峰值,60个月时仅为28.6%)的目标参数达到最多。不到34%的患者达到了PTH的推荐范围。结论:甲状旁腺切除术并不是达到NKF-K/DOQI推荐的所有生化指标的最佳手术方式。虽然它有助于达到对药物治疗有抵抗力的SHPT患者血清钙和磷酸盐的推荐值,但PTH水平并未落在推荐范围内。
{"title":"Achievement of the National Kidney Foundation Kidney Disease Outcomes Quality Initiative: recommended serum calcium, phosphate and parathyroid hormone values with parathyroidectomy in patients with secondary hyperparathyroidism.","authors":"Woo Young Kim,&nbsp;Jae Bok Lee,&nbsp;Hoon Yub Kim,&nbsp;Sang Uk Woo,&nbsp;Gil Soo Son,&nbsp;Jeoung Won Bae","doi":"10.4174/jkss.2013.85.1.25","DOIUrl":"https://doi.org/10.4174/jkss.2013.85.1.25","url":null,"abstract":"<p><strong>Purpose: </strong>The National Kidney Foundation Kidney Disease Outcomes Quality Initiative (NKF-K/DOQI) 2003 has established guidelines for the treatment of secondary hyperparathyroidism (SHPT) in patients with chronic kidney disease - minerals and bone disorder (CKD-MBD). This study evaluated parathyroidectomy in SHPT patients for the achievement of the NKF-K/DOQI-recommended values of serum calcium, phosphate, and parathyroid hormone (PTH).</p><p><strong>Methods: </strong>Between January 2005 and December 2010, parathyroidectomy was performed as recommended by the NKF-K/DOQI guidelines in 81 patients with SHPT and CKD-MBD. Serum PTH, calcium, and phosphate levels were measured prior to and 6, 12, 36, and 60 months after parathyroidectomy.</p><p><strong>Results: </strong>Calcium, phosphate, and PTH levels dropped shortly after parathyroidectomy; however, a slight increase showed in the long term. Calcium levels increased for up to 60 months. Phosphate and PTH levels increased for up to 36 months but tended to decrease slightly at 60 months. The mean values were within the target ranges, except for PTH at 36 months. The target parameters of serum phosphate (42.9-61.1% of patients) and serum calcium (a peak of 61.1% of patients at 36 months, but only 28.6% at 60 months) were achieved the most. Less than 34% of patients achieved the recommended range for PTH.</p><p><strong>Conclusion: </strong>Parathyroidectomy was not an optimal procedure for achieving all the biochemical parameters recommended by the NKF-K/DOQI. Although it was helpful in attaining the recommended values for serum calcium and phosphate in SHPT patients resistant to medical therapy, the PTH levels did not fall within the recommended range.</p>","PeriodicalId":49991,"journal":{"name":"Journal of the Korean Surgical Society","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2013-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.4174/jkss.2013.85.1.25","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"31563103","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 7
Experience of treatment of patients with granulomatous lobular mastitis. 肉芽肿性小叶性乳腺炎的治疗体会。
Pub Date : 2013-07-01 Epub Date: 2013-06-26 DOI: 10.4174/jkss.2013.85.1.1
Sung Mo Hur, Dong Hui Cho, Se Kyung Lee, Min-Young Choi, Soo Youn Bae, Min Young Koo, Sangmin Kim, Jun-Ho Choe, Jung-Han Kim, Jee Soo Kim, Seok-Jin Nam, Jung-Hyun Yang, Jeong Eon Lee

Purpose: To present the author's experience with various treatment methods of granulomatous lobular mastitis (GLM) and to determine effective treatment methods of GLM.

Methods: Fifty patients who were diagnosed with GLM were classified into five groups based on the initial treatment methods they underwent, which included observation (n = 8), antibiotics (n = 3), steroid (n = 13), drainage (n = 14), and surgical excision (n = 12). The treatment processes in each group were examined and their clinical characteristics, treatment processes, and results were analyzed respectively.

Results: Success rates with each initial treatment were observation, 87.5%; antibiotics, 33.3%; steroids, 30.8%; drainage, 28.6%; and surgical excision, 91.7%. In most cases of observation, the lesions were small and the symptoms were mild. A total of 23 patients underwent surgical excision during treatment. Surgical excision showed particularly fast recovery, high success rate (90.3%) and low recurrence rate (8.7%).

Conclusion: The clinical course of GLM is complex and the outcome of each treatment type are variable. Surgery may play an important role when a lesion is determined to be mass-forming or appears localized as an abscess pocket during breast examination or imaging study.

目的:介绍笔者对小叶性肉芽肿性乳腺炎(GLM)各种治疗方法的体会,探讨GLM的有效治疗方法。方法:50例确诊为GLM的患者根据初始治疗方法分为5组,分别为观察(n = 8)、抗生素(n = 3)、类固醇(n = 13)、引流(n = 14)、手术切除(n = 12)。观察各组患者的治疗过程,分析其临床特点、治疗过程及结果。结果:每次初始治疗的成功率为87.5%;抗生素,33.3%;类固醇,30.8%;排水、28.6%;手术切除占91.7%。在大多数观察病例中,病变小,症状轻。治疗期间共有23例患者接受了手术切除。手术切除恢复快,成功率高(90.3%),复发率低(8.7%)。结论:GLM临床病程复杂,各种治疗方法疗效不一。在乳房检查或影像学检查中,当病变被确定为肿块形成或表现为局部脓肿袋时,手术可能起重要作用。
{"title":"Experience of treatment of patients with granulomatous lobular mastitis.","authors":"Sung Mo Hur,&nbsp;Dong Hui Cho,&nbsp;Se Kyung Lee,&nbsp;Min-Young Choi,&nbsp;Soo Youn Bae,&nbsp;Min Young Koo,&nbsp;Sangmin Kim,&nbsp;Jun-Ho Choe,&nbsp;Jung-Han Kim,&nbsp;Jee Soo Kim,&nbsp;Seok-Jin Nam,&nbsp;Jung-Hyun Yang,&nbsp;Jeong Eon Lee","doi":"10.4174/jkss.2013.85.1.1","DOIUrl":"https://doi.org/10.4174/jkss.2013.85.1.1","url":null,"abstract":"<p><strong>Purpose: </strong>To present the author's experience with various treatment methods of granulomatous lobular mastitis (GLM) and to determine effective treatment methods of GLM.</p><p><strong>Methods: </strong>Fifty patients who were diagnosed with GLM were classified into five groups based on the initial treatment methods they underwent, which included observation (n = 8), antibiotics (n = 3), steroid (n = 13), drainage (n = 14), and surgical excision (n = 12). The treatment processes in each group were examined and their clinical characteristics, treatment processes, and results were analyzed respectively.</p><p><strong>Results: </strong>Success rates with each initial treatment were observation, 87.5%; antibiotics, 33.3%; steroids, 30.8%; drainage, 28.6%; and surgical excision, 91.7%. In most cases of observation, the lesions were small and the symptoms were mild. A total of 23 patients underwent surgical excision during treatment. Surgical excision showed particularly fast recovery, high success rate (90.3%) and low recurrence rate (8.7%).</p><p><strong>Conclusion: </strong>The clinical course of GLM is complex and the outcome of each treatment type are variable. Surgery may play an important role when a lesion is determined to be mass-forming or appears localized as an abscess pocket during breast examination or imaging study.</p>","PeriodicalId":49991,"journal":{"name":"Journal of the Korean Surgical Society","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2013-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.4174/jkss.2013.85.1.1","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"31206831","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 45
Early experiences of minimally invasive surgery to treat gastroesophageal reflux disease. 微创手术治疗胃食管反流病的早期体会。
Pub Date : 2013-06-01 Epub Date: 2013-05-28 DOI: 10.4174/jkss.2013.84.6.330
Sae Byul Lee, Kyoung Mo Jeon, Beom Su Kim, Kab Choong Kim, Hwoon-Yong Jung, Youn Baik Choi

Purpose: There are fewer patients with gastroesophageal reflux disease (GERD) in Korea compared with Western countries. The incidence of GERD has increased in recent years however, concerning many physicians. Here, we report our early experiences of using a recently introduced method of laparoscopic antireflux surgery for the treatment of GERD in Korean patients.

Methods: Fifteen patients with GERD were treated using antireflux surgery between May 2009 and February 2012 at the University of Ulsan College of Medicine and Asan Medical Center. Laparoscopic Nissen fundoplication with 360° wrapping was performed on all patients.

Results: Eleven male and four female patients were evaluated and treated with an average age of 58.1 ± 14.1 years. The average surgical time was 118.9 ± 45.1 minutes, and no complications presented during surgery. After surgery, the reflux symptoms of each patient were resolved; only two patients developed transient dysphagia, which resolved within one month. One patient developed a 6-cm hiatal hernia that had to be repaired and reinforced using mesh.

Conclusion: The use of laparoscopic surgery for the treatment of GERD is safe and feasible. It is also an efficacious method for controlling the symptoms of GERD in Korean patients. However, the use of this surgery still needs to be standardized (e.g., type of surgery, bougienage size, wrap length) and the long-term outcomes need to be evaluated.

目的:与西方国家相比,韩国胃食管反流病(GERD)患者较少。然而,近年来胃食管反流的发病率有所增加,这引起了许多医生的关注。在这里,我们报告了我们使用最近引入的腹腔镜抗反流手术治疗韩国患者反流的早期经验。方法:2009年5月至2012年2月,在蔚山大学医学院和峨山医学中心接受抗反流手术治疗的15例胃食管反流患者。所有患者均行360°腹腔镜尼森复底术。结果:男性11例,女性4例,平均年龄58.1±14.1岁。平均手术时间为118.9±45.1 min,术中无并发症发生。术后患者反流症状均得到缓解;仅有2例患者出现短暂性吞咽困难,并在1个月内消退。一名患者出现6厘米裂孔疝,必须使用补片进行修复和加固。结论:腹腔镜手术治疗胃食管反流安全可行。这也是韩国患者控制胃食管反流症状的有效方法。然而,这种手术的使用仍然需要标准化(例如,手术类型,花束大小,包皮长度),并且需要评估长期结果。
{"title":"Early experiences of minimally invasive surgery to treat gastroesophageal reflux disease.","authors":"Sae Byul Lee,&nbsp;Kyoung Mo Jeon,&nbsp;Beom Su Kim,&nbsp;Kab Choong Kim,&nbsp;Hwoon-Yong Jung,&nbsp;Youn Baik Choi","doi":"10.4174/jkss.2013.84.6.330","DOIUrl":"https://doi.org/10.4174/jkss.2013.84.6.330","url":null,"abstract":"<p><strong>Purpose: </strong>There are fewer patients with gastroesophageal reflux disease (GERD) in Korea compared with Western countries. The incidence of GERD has increased in recent years however, concerning many physicians. Here, we report our early experiences of using a recently introduced method of laparoscopic antireflux surgery for the treatment of GERD in Korean patients.</p><p><strong>Methods: </strong>Fifteen patients with GERD were treated using antireflux surgery between May 2009 and February 2012 at the University of Ulsan College of Medicine and Asan Medical Center. Laparoscopic Nissen fundoplication with 360° wrapping was performed on all patients.</p><p><strong>Results: </strong>Eleven male and four female patients were evaluated and treated with an average age of 58.1 ± 14.1 years. The average surgical time was 118.9 ± 45.1 minutes, and no complications presented during surgery. After surgery, the reflux symptoms of each patient were resolved; only two patients developed transient dysphagia, which resolved within one month. One patient developed a 6-cm hiatal hernia that had to be repaired and reinforced using mesh.</p><p><strong>Conclusion: </strong>The use of laparoscopic surgery for the treatment of GERD is safe and feasible. It is also an efficacious method for controlling the symptoms of GERD in Korean patients. However, the use of this surgery still needs to be standardized (e.g., type of surgery, bougienage size, wrap length) and the long-term outcomes need to be evaluated.</p>","PeriodicalId":49991,"journal":{"name":"Journal of the Korean Surgical Society","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2013-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.4174/jkss.2013.84.6.330","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"31486549","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 7
Reconstruction of portal vein and superior mesenteric vein after extensive resection for pancreatic cancer. 胰腺癌广泛切除后门静脉及肠系膜上静脉重建。
Pub Date : 2013-06-01 Epub Date: 2013-05-28 DOI: 10.4174/jkss.2013.84.6.346
Suh Min Kim, Seung-Kee Min, Daedo Park, Sang-Il Min, Jin-Young Jang, Sun-Whe Kim, Jongwon Ha, Sang Joon Kim

Purpose: Tumor invasion to the portal vein (PV) or superior mesenteric vein (SMV) can be encountered during the surgery for pancreatic cancer. Venous reconstruction is required, but the optimal surgical methods and conduits remain in controversies.

Methods: From January 2007 to July 2012, 16 venous reconstructions were performed during surgery for pancreatic cancer in 14 patients. We analyzed the methods, conduits, graft patency, and patient survival.

Results: The involved veins were 14 SMVs and 2 PVs. The operative methods included resection and end-to-end anastomosis in 7 patients, wedge resection with venoplasty in 2 patients, bovine patch repair in 3 patients, and interposition graft with bovine patch in 1 patient. In one patient with a failed interposition graft with great saphenous vein (GSV), the SMV was reconstructed with a prosthetic interposition graft, which was revised with a spiral graft of GSV. Vascular morbidity occurred in 4 cases; occlusion of an interposition graft with GSV or polytetrafluoroethylene, segmental thrombosis and stenosis of the SMV after end-to-end anastomosis. Patency was maintained in patients with bovine patch angioplasty and spiral vein grafts. With mean follow-up of 9.8 months, the 6- and 12-month death-censored graft survival rates were both 81.3%.

Conclusion: Many of the involved vein segments were repaired primarily. When tension-free anastomosis is impossible, the spiral grafts with GSV or bovine patch grafts are good options to overcome the size mismatch between autologous vein graft and portomesenteric veins. Further follow-up of these patients is needed to demonstrate long-term patency.

目的:胰腺癌手术中肿瘤侵犯门静脉(PV)或肠系膜上静脉(SMV)。静脉重建是必要的,但最佳的手术方法和导管仍然存在争议。方法:2007年1月至2012年7月,对14例胰腺癌患者行16例术中静脉重建。我们分析了方法、导管、移植物通畅和患者生存率。结果:受累静脉为中静脉14条,静脉2条。手术方式包括切除端到端吻合7例,楔形切除联合静脉成形术2例,牛补片修复3例,牛补片间置移植1例。在一例大隐静脉(GSV)间置移植物失败的患者中,用假体间置移植物重建SMV,并用GSV螺旋移植物修复SMV。血管病变4例;端到端吻合后GSV或聚四氟乙烯间置移植物闭塞、节段性血栓形成和SMV狭窄。牛膜片血管成形术和螺旋静脉移植患者保持通畅。平均随访9.8个月,6个月和12个月死亡后移植存活率均为81.3%。结论:许多受累静脉段得到了初步修复。当无张力吻合无法实现时,采用GSV螺旋形移植物或牛膜片移植物是克服自体静脉移植物与肠系膜静脉大小不匹配的较好选择。需要对这些患者进行进一步随访以证明其长期通畅。
{"title":"Reconstruction of portal vein and superior mesenteric vein after extensive resection for pancreatic cancer.","authors":"Suh Min Kim,&nbsp;Seung-Kee Min,&nbsp;Daedo Park,&nbsp;Sang-Il Min,&nbsp;Jin-Young Jang,&nbsp;Sun-Whe Kim,&nbsp;Jongwon Ha,&nbsp;Sang Joon Kim","doi":"10.4174/jkss.2013.84.6.346","DOIUrl":"https://doi.org/10.4174/jkss.2013.84.6.346","url":null,"abstract":"<p><strong>Purpose: </strong>Tumor invasion to the portal vein (PV) or superior mesenteric vein (SMV) can be encountered during the surgery for pancreatic cancer. Venous reconstruction is required, but the optimal surgical methods and conduits remain in controversies.</p><p><strong>Methods: </strong>From January 2007 to July 2012, 16 venous reconstructions were performed during surgery for pancreatic cancer in 14 patients. We analyzed the methods, conduits, graft patency, and patient survival.</p><p><strong>Results: </strong>The involved veins were 14 SMVs and 2 PVs. The operative methods included resection and end-to-end anastomosis in 7 patients, wedge resection with venoplasty in 2 patients, bovine patch repair in 3 patients, and interposition graft with bovine patch in 1 patient. In one patient with a failed interposition graft with great saphenous vein (GSV), the SMV was reconstructed with a prosthetic interposition graft, which was revised with a spiral graft of GSV. Vascular morbidity occurred in 4 cases; occlusion of an interposition graft with GSV or polytetrafluoroethylene, segmental thrombosis and stenosis of the SMV after end-to-end anastomosis. Patency was maintained in patients with bovine patch angioplasty and spiral vein grafts. With mean follow-up of 9.8 months, the 6- and 12-month death-censored graft survival rates were both 81.3%.</p><p><strong>Conclusion: </strong>Many of the involved vein segments were repaired primarily. When tension-free anastomosis is impossible, the spiral grafts with GSV or bovine patch grafts are good options to overcome the size mismatch between autologous vein graft and portomesenteric veins. Further follow-up of these patients is needed to demonstrate long-term patency.</p>","PeriodicalId":49991,"journal":{"name":"Journal of the Korean Surgical Society","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2013-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.4174/jkss.2013.84.6.346","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"31486551","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 20
期刊
Journal of the Korean Surgical Society
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1